Chris Hill
Analyst · Wolfe Research. Please go ahead
Thanks Larry. In the third quarter, the company cost reduction plans both Phase 1 and Phase 2 that were previously announced were fully implemented. Although, revenue continued to decline, the cost reductions help mitigate the impact and provide a slight improvement to earnings over last quarter. As Larry stated earlier, the company continued to focus on reducing debt and improving its liquidity position and reduce net debt by $16.2 million during the third quarter. Additionally, on October 16, we announced entering an agreement to issue $60 million in senior notes through a private placement. The new notes will be funded on January 12, 2021 and have a five-year maturity on $45 million and a seven-year maturity on the other $15 million. We are pleased with both the terms under the new notes and support from our lenders as this transaction accomplishes two goals as we manage the company's corporate debt structure through current environment. First, it provides additional liquidity under the company's revolving credit facility, which will be used to address the outstanding $75 million senior notes maturing September 30, 2021. And second, issuing $60 million in new notes and retiring $75 million of senior notes next year is an additional step towards longer term strategy of reducing debt and Core Lab’s debt leverage ratio. The new notes also include financial covenants, which are aligned with the financial covenants under our existing credit facility. As a reminder, the more restrictive of these covenants is the maximum leverage ratio, which is currently limited to three times EBITDA and the company's leverage ratio was 2.49 times as of September 30. We continue to project, Core Lab will remain profitable, compliant with the financial covenants under our debt agreements and generate free cash flow, which will continue to be focused on reducing debt for the foreseeable future. Before we review the financial performance for the quarter, the guidance we gave on our last call and past calls specifically excluded the impact of any FX gains or losses and assumed an effective tax rate of 20%. So accordingly, our discussion today excludes any foreign exchange gain or loss for current and prior periods. Additionally, the financial results for the third quarter of 2020 include $1.5 million of fees and expenses associated with professional services used in evaluating various corporate debt refinancing opportunities. These additional fees and expenses were classified as interest expense and have also been excluded from the financial results discussed today. Now looking at the income statement, revenue from continuing operations was $105.4 million in the third quarter, down approximately 9% from $115.7 million in the prior quarter. The decline is the result of a 16% decrease in both international project revenue and product sales as disruptions and delays caused by COVID-19. However, sequential decline in international activities was partially offset by a more active U.S. land market from which Core Lab grew its revenue over 21% compared to the second quarter. Of this revenue, service revenue which is more international was $86.3 million for the quarter, down from $91 million or about 5% sequentially. Service revenue was most notably impacted by delays on international projects, due to COVID-19 disruptions, which started at the end of the first quarter and continued through the second quarter. Although, some activities on these larger projects have recommenced during the third quarter, the disruptions to project workflows in our laboratories have resulted in lower revenue for the third quarter. Our network of laboratories across the globe has remained open and operational throughout the third quarter. And as activities returned to project well sites and our client's facilities, our ability to advance existing projects for clients will improve. However, the COVID-19 pandemic has created additional challenges for operators and service companies to navigate resulting in additional costs and operational inefficiencies, which are expected to continue in the fourth quarter. Additionally, the afore-named weather storms, which impacted the Gulf of Mexico during the third quarter, also delayed some offshore projects and reservoir fluids analysis conducted by some of our coastal facilities in the region. Product sales, which historically were more tied to North American activity have shifted and are now comprised of more sales to international markets. Product sales for the quarter were $19.1 million, a decrease of 23% from $24.7 million last quarter. Product sales to the U.S. market were up 32% sequentially, coming off the second quarter low. This improvement in the U.S. market was offset by a sequential decrease in international product sales of both perforating systems and laboratory instrumentation. International well site locations, as well as laboratory and research facilities of our clients continue to be impacted by COVID-19 causing delays in the delivery of products and laboratory instrumentation. Moving on to cost of services, for the quarter 74% of service revenue, which is consistent with prior quarter. As the decline in service revenue was mitigated by cost reduction initiatives more fully implemented during the quarter. Cost of sales in the third quarter was 90% of revenue, improved from 96% last quarter, again, as cost reduction initiatives were completed and more fully realized this quarter. G&A ex-items for the quarter was $9.2 million, down slightly from $9.5 million last quarter. Depreciation and amortization for the quarter is $5.2 million, down from $5.4 million, reflecting lower capital expenditures in 2020. For the full year, we continue to project capital expenditures to be in that $11 million to $12 million range. EBIT ex-items for the quarter was $12.3 million, up from $10.7 million last quarter. And given the current environment continues to represent EBIT margins of 12%. Additionally, cost reduction initiatives completed during the quarter and despite decline in revenue even improved this quarter. The actions taken to align our cost structure positions the company well as the energy market continues to progress towards balancing supply and demand. Our operating income for the quarter on a GAAP basis was $11.3 million. Income tax expense ex-items and using an effective tax rate of 20% for the quarter was $1.8 million on a GAAP basis, the company recorded income tax expense of $3.7 million. The unusual events of 2020 and impairment adjustments recorded earlier in the year have also skewed the company's effective tax rate for 2020. As we project future operational results, we continue to project the company's effective tax rate will approximate 20%. For the remainder of 2020, the effective tax rate will continue to be somewhat sensitive to the geographic mix of earnings across the globe and the impact of items that are discrete to each quarter. Income from continuing operations ex-items for the quarter was $7.3 million, up 20% sequentially from $6.1 million. GAAP income from continuing operations was $3 million for the third quarter of 2020. Earnings per diluted share from continuing operations ex-items was $0.16 for the quarter. GAAP earnings per share from continuing operations for the third quarter was $0.07. Now we'll move on to the balance sheet. Receivables were $85.4 million and decreased approximately $16 million from prior quarter. Our DSOs were at 68 days for the third quarter, a noticeable improvement from the 74 days last quarter. We will continue to monitor our collections closely as we currently do not anticipate significant changes in payment practices from our client base. Inventory was $42.9 million up approximately $1.4 million from last quarter end, primarily due to delayed shipments to international markets. The company expects inventory levels to decrease in the fourth quarter as delayed shipments are completed and assuming completion activity in the U.S. land market remain stable or improves from current levels. And now on to the liability side of the balance sheet. Our long-term debt, which includes $75 million of senior notes maturing next year was $266 million at quarter end. And considering cash of $15 million net debt was reduced to $251 million or a decrease of $16.2 million. Our debt is comprised of our senior notes at $150 million, as well as $116 million outstanding under our bank revolving credit facility. As stated earlier, the company entered into an agreement to issue $60 million of new notes in January of 2021, as we extend the maturity for a portion of the debt coming due next year. Looking to cash flow in the third quarter, cash flow from operating activities was $20.7 million, and after paying for $2.2 million in CapEx, our free cash flow in Q3 was $18.5 million. In case you missed the earlier comment for 2020, the company anticipates that its CapEx will be $11 million to $12 million or down approximately 50% compared to 2019. As we project cash flow for future periods, we would expect less contribution from working capital. This also marks the 76 consecutive quarter Core Lab has generated positive free cash flow. And we are projecting to continue generating positive free cash, as we manage the organization through the challenging market ahead. We believe evaluating a company's ability to generate free cash flow and free cash flow yield is an important metric for shareholders when comparing company’s financial results, particularly for those shareholders who utilize discounted cash flow models to assess valuations. I will now turn it over to Gwen for an update on our guidance and outlook.